This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis (id = "example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort")
<?xml version="1.0" encoding="UTF-8"?> <EvidenceVariable xmlns="http://hl7.org/fhir"> <id value="example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis </p> </div> </text> <name value="Stroke Thrombolysis Trialists’ 2014-2016 IPD-MA Cohort"/> <title value="Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis"/> <status value="draft"/> <relatedArtifact> <type value="citation"/> <label value="Emberson 2014"/> <display value="Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials."/> <citation value="Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063"/> <url value="https://doi.org/10.1016/S0140-6736(14)60584-5"/> </relatedArtifact> <relatedArtifact> <type value="citation"/> <label value="Lees 2016"/> <display value="Figure 2 Lees 2016"/> <citation value="Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856"/> <url value="https://doi.org/10.1161/STROKEAHA.116.013644"/> </relatedArtifact> <actual value="true"/> <characteristicCombination value="union"/> <characteristic> <definitionReference> <reference value="Group/ECASSIII-Trial-Cohort"/> <type value="Group"/> <display value="ECASS III Trial Cohort"/> </definitionReference> </characteristic> <characteristic> <definitionReference> <reference value="Group/IST3-Trial-Cohort"/> <type value="Group"/> <display value="IST3 Trial Cohort"/> </definitionReference> </characteristic> <characteristic> <definitionReference> <reference value="Group/ECASS-Trial-Cohort"/> <type value="Group"/> <display value="ECASS Trial Cohort"/> </definitionReference> </characteristic> <characteristic> <definitionReference> <reference value="Group/ECASSII-Trial-Cohort"/> <type value="Group"/> <display value="ECASSII Trial Cohort"/> </definitionReference> </characteristic> <characteristic> <definitionReference> <reference value="Group/EPITHET-Trial-Cohort"/> <type value="Group"/> <display value="EPITHET Trial Cohort"/> </definitionReference> </characteristic> <characteristic> <definitionReference> <reference value="Group/ATLANTIS-Trial-Cohort"/> <type value="Group"/> <display value="ATLANTIS Trial Cohort"/> </definitionReference> </characteristic> <characteristic> <definitionReference> <reference value="Group/NINDS-Trial-Cohort"/> <type value="Group"/> <display value="NINDS Trial Cohort"/> </definitionReference> </characteristic> </EvidenceVariable>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.